Lineage Cell Therapeutics, Inc.·4

Mar 19, 5:00 PM ET

Hogge Gary S. 4

4 · Lineage Cell Therapeutics, Inc. · Filed Mar 19, 2020

Insider Transaction Report

Form 4
Period: 2020-03-17
Hogge Gary S.
SVP,Clinical & Medical Affairs
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-03-17+444,000444,000 total
    Exercise: $0.69Exp: 2030-03-17Common Shares (444,000 underlying)
Footnotes (1)
  • [F1]One quarter of the options shall vest on March 17, 2021 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

Documents

2 files